EP 2173728 A2 20100414 - HETEROCYCLIC MODULATORS OF PKB
Title (en)
HETEROCYCLIC MODULATORS OF PKB
Title (de)
HETEROCYCLISCHE PKB-MODULATOREN
Title (fr)
MODULATEURS HÉTÉROCYCLIQUES DE PKB
Publication
Application
Priority
- US 2008008723 W 20080716
- US 95997207 P 20070717
Abstract (en)
[origin: WO2009011880A2] The invention relates to heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein Formula (I). The invention also relates to the therapeutic use of such compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
IPC 8 full level
C07D 263/48 (2006.01); A61K 31/41 (2006.01); A61K 31/5377 (2006.01); A61P 35/00 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 413/04 (2006.01); C07D 413/14 (2006.01); C07D 417/04 (2006.01)
CPC (source: EP US)
A61P 3/00 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 263/48 (2013.01 - EP US); C07D 401/04 (2013.01 - EP US); C07D 403/04 (2013.01 - EP US); C07D 405/04 (2013.01 - EP US); C07D 409/04 (2013.01 - EP US); C07D 413/04 (2013.01 - EP US); C07D 413/14 (2013.01 - EP US); C07D 417/04 (2013.01 - EP US)
Citation (search report)
See references of WO 2009011880A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
WO 2009011880 A2 20090122; WO 2009011880 A3 20090402; AU 2008276521 A1 20090122; AU 2008276521 B2 20111103; CA 2692713 A1 20090122; EP 2173728 A2 20100414; JP 2010533715 A 20101028; US 2009275592 A1 20091105; US 7897619 B2 20110301
DOCDB simple family (application)
US 2008008723 W 20080716; AU 2008276521 A 20080716; CA 2692713 A 20080716; EP 08794537 A 20080716; JP 2010517014 A 20080716; US 21875408 A 20080716